Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4361 studies found for:    Open Studies | "Brain Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Brain Diseases" (4361 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Conditions: Hepatocerebral Encephalopathy;   Portal-Systemic Encephalopathy;   Encephalopathy, Hepatic;   Encephalopathy, Hepatocerebral
Interventions: Drug: Lactulose;   Drug: Placebo
2 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
3 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
4 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
5 Unknown  The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
6 Recruiting Preemie Hypothermia for Neonatal Encephalopathy
Conditions: Infant, Newborn;   Hypoxia, Brain;   Hypoxia-Ischemia, Brain;   Encephalopathy, Hypoxic-Ischemic;   Hypoxic-Ischemic Encephalopathy;   Ischemic-Hypoxic Encephalopathy
Interventions: Device: Hypothermia;   Procedure: Normothermic Control
7 Recruiting Metformin Experience on Minimal Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Metformin;   Drug: Placebo
8 Recruiting The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Nitazoxanide;   Drug: Oral lactulose;   Drug: Metronidazole;   Drug: Rifaximine
9 Recruiting Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Conditions: Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention: Other: Autologous umbilical cord blood cells
10 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
11 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
12 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
13 Recruiting L-ornithine L-aspartate in Overt Hepatic Encephalopathy
Conditions: Cirrhosis of Liver;   Hepatic Encephalopathy
Interventions: Drug: L-ornithine L-aspartate;   Drug: Placebo
14 Unknown  A Nutritional Approach to Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Intervention: Other: Nutritional Intervention
15 Unknown  Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate and lactulose;   Drug: placebo and lactulose
16 Unknown  ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
Condition: Hepatic Encephalopathy
Intervention: Dietary Supplement: probiotic VSL#3
17 Unknown  Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy.
Intervention: Drug: Rifaximin-α
18 Unknown  Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
Conditions: Severe Hypoxic Ischemic Encephalopathy;   Moderate Hypoxic Ischemic Encephalopathy
Interventions: Drug: Magnesium Sulphate;   Drug: Placebo
19 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
20 Recruiting Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Cirrhosis
Interventions: Drug: Human albumin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years